US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Invesco Dorsey Wright Healthcare Momentum ETF

60.94

+0.17080.28%

Volume:35.59K

Turnover:2.17M

Market Cap:284.59M

PE:19.93

High:60.98

Open:60.98

Low:60.60

Close:60.77

52wk High:64.10

52wk Low:39.36

Shares:4.67M

Float Shares:4.67M

Volume Ratio:44.74

T/O Rate:0.76%

Dividend:1.53

Dividend Rate:2.50%

EPS(TTM):3.06

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Guardant Health Chief People Officer Terilyn Monroe Disposes of Common Shares Worth $7.61 Million

BrightSpring Health Svcs Price Target Maintained with a $90.00/Share by BTIG

Cullinan Climbs as Lung Cancer Drug Meets Late-Stage Trial Goal

Transformation Drive: How a 1 Billion Yuan Capacity Firm Used Shanghai's First Medical Device License to Unlock Nanxiang Life Valley's 'Rainforest' Incubation Path

Shuozhou City Market Regulation Bureau Conducts Cross-Inspection of Medical Device Safety

Medical Equipment Procurement Shows Sustained Monthly Recovery, Sector Valuations Poised for Rebound

Propanc Biopharma Highlights Differentiated Proenzyme Therapy PRP as a Potential Therapy of Choice Against RAS-Driven Cancers

Liquidia Q2 Revenue Jumps on Yutrepia Sales

Axsome Therapeutics (AXSM) Receives a Buy from Mizuho Securities

Ningyang County Market Regulation Bureau Launches Special Inspection on Optometry Instruments

New Batch of National Standards Released, Including Autonomous Driving Safety and AI Medical Device Quality

Guardant Health Chief Commercial Officer Chris Freeman Disposes of $ 10.75 Million in Common Shares

Axsome's Auvelity Strength Expected to Drive H2 Revenue Growth, RBC Says

MT Newswires Live

Tango Falls After Wider-than-Expected Quarterly Loss

Analysts Offer Insights on Healthcare Companies: Cardinal Health (CAH), Axsome Therapeutics (AXSM) and BridgeBio Pharma (BBIO)

Axsome Therapeutics Analysts Increase Their Forecasts Following Q2 Results

Benzinga Earnings

U.S. Stocks on the MOVE-Duke Energy, Sea, Cardinal Health

Truist Raises Revolution Medicines PT on Lung Cancer Pipeline Potential

Fennec Pharmaceuticals Q2 Sales Rise on Pedmark Demand

BEONE MEDICINES Surges Over 4% in Morning Trading on Strategic Partnership with Revolution Medicines to Accelerate RAS Drug Development

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigreclipse.com/stock/PTH/news?page=8"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"PTH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PTH\",,,,,undefined,":{"symbol":"PTH","market":"US","secType":"STK","nameCN":"Invesco Dorsey Wright Healthcare Momentum ETF","latestPrice":60.94,"timestamp":1789393468489,"preClose":60.7692,"halted":0,"volume":35591,"delay":0,"changeRate":0.0028106343344983945,"floatShares":4670000,"shares":4670000,"eps":3.057033,"marketStatus":"Trading","change":0.1708,"latestTime":"09-14 09:44:35 EDT","open":60.98,"high":60.98,"low":60.6,"amount":2168465.812124,"amplitude":0.006253,"askPrice":60.94,"askSize":100,"bidPrice":60.73,"bidSize":1100,"shortable":3,"etf":1,"ttmEps":3.057033,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1789416000000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":60.7692,"sharesOutstanding":2480000,"nav":60.58293,"aum":283728993.67,"dividendRate":0.02503,"bidAskSpread":0.001903,"postHourTrading":{"tag":"盘后","latestPrice":60.85,"preClose":60.7692,"latestTime":"19:30 EDT","volume":14,"amount":850.1752,"timestamp":1789169406061,"change":0.0808,"changeRate":0.00133,"amplitude":0},"volumeRatio":44.736521,"impliedVol":0.1285,"impliedVolPercentile":0.5857},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PTH\",,,,,undefined,":{"symbol":"PTH","floatShares":4670000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":44.736521,"shares":4670000,"dividePrice":1.5253,"high":60.98,"amplitude":0.006253,"preClose":60.7692,"low":60.6,"week52Low":39.36,"pbRate":"--","week52High":64.1,"institutionHeld":0,"latestPrice":60.94,"committee":0.833333,"eps":3.057033,"divideRate":0.02503,"volume":35591,"delay":0,"ttmEps":3.057033,"open":60.98,"prevYearClose":49.701,"prevWeekClose":60.7692,"prevMonthClose":60.7941,"prevQuarterClose":59.76,"fiveDayClose":61.1284,"twentyDayClose":60.35,"sixtyDayClose":52.7902},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PTH\",params:#limit:5,,,undefined,":[{"date":"2025-12-22","symbol":"PTH","amount":1.52645,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"Invesco Dorsey Wright Healthcare Momentum ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2024-06-24","symbol":"PTH","amount":0.02545,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-24","defaultRemindTime":1719235800000,"name":"Invesco Dorsey Wright Healthcare Momentum ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-06-28","payableDate":"2024-06-24","currency":"USD","dateTimestamp":1719201600000,"payDate":"2024-06-28"},{"market":"US","date":"2023-07-17","symbol":"PTH","defaultRemindTime":1689600600000,"type":"split","dateTimestamp":1689566400000,"forFactor":1,"toFactor":3,"ratio":0.3333333333333333}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PTH\",market:\"US\",,,undefined,":[{"executeDate":"2024-06-24","recordDate":"2024-06-24","paymentDate":"2024-06-28","value":0.02545,"currency":"USD"},{"executeDate":"2025-12-22","recordDate":"2025-12-22","paymentDate":"2025-12-26","value":1.52645,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PTH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PTH\",pageSize:20,pageCount:8,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2659719596","title":"Guardant Health Chief People Officer Terilyn Monroe Disposes of Common Shares Worth $7.61 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2659719596","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659719596?lang=en_us&edition=fundamental","pubTime":"2026-08-14 07:21","pubTimestamp":1786663307,"startTime":"0","endTime":"0","summary":"Guardant Health Chief People Officer Terilyn Monroe disposes of common shares worth $7.61 millionGuardant Health Chief People Officer Terilyn J. Monroe cut her direct common stock stake to 22,979 shar","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nNDL1rsYJl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Guardant Health Chief People Officer Terilyn Monroe Disposes of Common Shares Worth $7.61 Million","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EKG","GDOC","BK4551","BK4196","GH","LU0320765992.SGD","LU0889565916.HKD","BK4585","FFOX","BK4535","HELX","LU0109394709.USD","GNOM","PTH","GNMX","BK4588","LFSC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659156635","title":"BrightSpring Health Svcs Price Target Maintained with a $90.00/Share by BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2659156635","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659156635?lang=en_us&edition=fundamental","pubTime":"2026-08-13 19:03","pubTimestamp":1786618980,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/BTSG/analyst-ratings","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2468319806.SGD","LU2089984988.USD","PSCH","BTSG","BK4196","LU2324357040.USD","PTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659130742","title":"Cullinan Climbs as Lung Cancer Drug Meets Late-Stage Trial Goal","url":"https://stock-news.laohu8.com/highlight/detail?id=2659130742","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659130742?lang=en_us&edition=fundamental","pubTime":"2026-08-13 17:39","pubTimestamp":1786613984,"startTime":"0","endTime":"0","summary":"BUZZ-Cullinan climbs as lung cancer drug meets late-stage trial goal** Shares of Cullinan TherapeuticsCGEM.Orise 6% to $20.77 premarket** Cullinan says its experimental cancer drug, zipalertinib, when","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nL4N44A0QA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765992.SGD","IE0009355771.USD","IE00BJT1NW94.SGD","BK4139","RVMD","CANC","IE00BFTCPJ56.SGD","IE0009354923.USD","IE00B2B36J28.USD","LU0109394709.USD","LU0889565916.HKD","IE00BJJMRZ35.SGD","IE00B4R5TH58.HKD","IE0002141913.USD","CGEM","BBH","PTH","IDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1151434530","title":"Transformation Drive: How a 1 Billion Yuan Capacity Firm Used Shanghai's First Medical Device License to Unlock Nanxiang Life Valley's 'Rainforest' Incubation Path","url":"https://stock-news.laohu8.com/highlight/detail?id=1151434530","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1151434530?lang=en_us&edition=fundamental","pubTime":"2026-08-13 15:40","pubTimestamp":1786606856,"startTime":"0","endTime":"0","summary":"In the first half of this year, Jiading District's strategic emerging industries accounted for 41.4% of total industrial output value above a designated size, with the three leading sectors achieving...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IEIH","09996","GDOC","AGNG","PTH","MDEV","RSPH","LNGR","HART","MEDX","LGHT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1163427165","title":"Shuozhou City Market Regulation Bureau Conducts Cross-Inspection of Medical Device Safety","url":"https://stock-news.laohu8.com/highlight/detail?id=1163427165","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1163427165?lang=en_us&edition=fundamental","pubTime":"2026-08-13 13:50","pubTimestamp":1786600255,"startTime":"0","endTime":"0","summary":"Shuozhou City Market Regulation Bureau has recently intensified oversight of medical device quality and safety across the entire supply chain, from distribution to clinical use. The initiative aims...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09996","PTH","LGHT","AGNG","IEIH","BK1583","GDOC","LNGR","MDEV","MEDX","BK1100","BK1574","159883","HART","RSPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128373791","title":"Medical Equipment Procurement Shows Sustained Monthly Recovery, Sector Valuations Poised for Rebound","url":"https://stock-news.laohu8.com/highlight/detail?id=1128373791","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1128373791?lang=en_us&edition=fundamental","pubTime":"2026-08-13 07:18","pubTimestamp":1786576706,"startTime":"0","endTime":"0","summary":"GTHT has released a research report noting that the ongoing implementation of equipment renewal policies is expected to drive long-term increases in medical equipment procurement levels. The...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RSPH","BK0188","BK0184","BK1583","MDEV","09996","IEIH","MEDX","BK1100","BK1564","BK0276","PTH","BK0201","BK0028","CZA","BK0183","BK0012","LCO","HART","159883","NIFE","REVS","AGNG","BK1147","GDOC","02611","BK1574","601211","LGHT","LNGR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658086429","title":"Propanc Biopharma Highlights Differentiated Proenzyme Therapy PRP as a Potential Therapy of Choice Against RAS-Driven Cancers","url":"https://stock-news.laohu8.com/highlight/detail?id=2658086429","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658086429?lang=en_us&edition=fundamental","pubTime":"2026-08-12 20:30","pubTimestamp":1786537800,"startTime":"0","endTime":"0","summary":"Contrasting Science with Revolution Medicines and ErascaMELBOURNE, Australia, Aug.  12, 2026 (GLOBE NEWSWIRE) -- Propanc Biopharma, Inc. (Nasdaq: PPCB) (“Propanc” or the “Company”), a biopharmaceutica","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/12/3343641/0/en/propanc-biopharma-highlights-differentiated-proenzyme-therapy-prp-as-a-potential-therapy-of-choice-against-ras-driven-cancers.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1861220033.SGD","LU2357305700.SGD","LU0109394709.USD","BK4141","IE00BFTCPJ56.SGD","BK4605","ON","LU1861219969.SGD","BK4139","PTH","IE0002141913.USD","LU1720051108.HKD","IDNA","ERAS","BK4512","IE00BD6J9T35.USD","BK4585","LU0348723411.USD","LU0124384867.USD","LU1854104046.USD","LU0320765992.SGD","PDX","CHH","LU1548497426.USD","IE00BJT1NW94.SGD","LU1861214812.USD","IE00BJJMRZ35.SGD","LU1720051017.SGD","LU1978683503.SGD","BK4539","LU2298322129.HKD","LU0889565916.HKD","BK4588","IE00B2B36J28.USD","LU1854103824.USD","LU1861215975.USD","LU0724618433.USD","LU2360107325.USD","IE00B4R5TH58.HKD","BBH","IE0009354923.USD","IE00BZ199S13.USD","CANC","RVMD","LU1983260115.SGD","IE0009355771.USD","BK4142","IE00BFMHRM44.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658979562","title":"Liquidia Q2 Revenue Jumps on Yutrepia Sales","url":"https://stock-news.laohu8.com/highlight/detail?id=2658979562","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658979562?lang=en_us&edition=fundamental","pubTime":"2026-08-12 18:39","pubTimestamp":1786531153,"startTime":"0","endTime":"0","summary":"Liquidia Q2 revenue jumps on YUTREPIA salesOverviewU.S. biopharma firm's Q2 sales revenue rose sharply on YUTREPIA salesEPS for Q2 met analyst expectationsCompany posted fourth consecutive quarter of ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nL1N4490C3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BBIO","LQDA","BK4505","AXSM","BK4585","BK4139","BK4588","PTH","LU2324357040.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658621979","title":"Axsome Therapeutics (AXSM) Receives a Buy from Mizuho Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2658621979","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658621979?lang=en_us&edition=fundamental","pubTime":"2026-08-12 18:36","pubTimestamp":1786530986,"startTime":"0","endTime":"0","summary":"Mizuho Securities analyst Graig Suvannavejh maintained a Buy rating on Axsome Therapeutics today and set a price target of $316.00. According to Ti...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/axsome-therapeutics-axsm-receives-a-buy-from-mizuho-securities-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/axsome-therapeutics-axsm-receives-a-buy-from-mizuho-securities-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4207","MFG","AXSM","BK4505","PTH","GSIB","LU2324357040.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126627296","title":"Ningyang County Market Regulation Bureau Launches Special Inspection on Optometry Instruments","url":"https://stock-news.laohu8.com/highlight/detail?id=1126627296","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1126627296?lang=en_us&edition=fundamental","pubTime":"2026-08-12 16:32","pubTimestamp":1786523522,"startTime":"0","endTime":"0","summary":"On August 11, enforcement officers from the Ningyang County Market Regulation Bureau in Shandong Province conducted a special medical device inspection at eyewear retail stores in the area. The...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PTH","RSPH","LNGR","09996","BK1583","HART","LGHT","MDEV","MEDX","BK1100","AGNG","GDOC","BK1574","IEIH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119178651","title":"New Batch of National Standards Released, Including Autonomous Driving Safety and AI Medical Device Quality","url":"https://stock-news.laohu8.com/highlight/detail?id=1119178651","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1119178651?lang=en_us&edition=fundamental","pubTime":"2026-08-12 15:21","pubTimestamp":1786519304,"startTime":"0","endTime":"0","summary":"A significant set of 338 national standards has been approved by the State Administration for Market Regulation's Standardization Administration.This release includes 15 mandatory and 323 recommended...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MDEV","NJUL","NAPR","IDRV","TECY","ROBT","HAIL","BK1100","MOTO","07522","WPAI","NOCT","PBOT","07568","KOMP","CWC","AIFD","CPNQ","MVPS","09996","FAI","07261","QMAR","159883","QQQM","DRIV","BK1583","PTH","DQJN","TQQQ","SQQQ","07266","TQQY","AGIX","AIBU","IEIH","QDEC","PSQ","LGHT","MFIG","09834","QQA","CHAT","NEWZ","161631","QQQ","02834","QQQX","09086","QID","TARK","LNGR","GK","FDIF","OGIG","GPIQ","IQM","RSPH","BK4593","03034","MEDX","BK1574","QSWN","NJAN","GDOC","FWD","NBDS","LCLG","QTOC","AGNG","QLD","AIQU","03086","CARZ","AQGX","VUSE","ARTY","XT","03455","HART"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658949165","title":"Guardant Health Chief Commercial Officer Chris Freeman Disposes of $ 10.75 Million in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2658949165","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658949165?lang=en_us&edition=fundamental","pubTime":"2026-08-12 06:23","pubTimestamp":1786487005,"startTime":"0","endTime":"0","summary":"Guardant Health Chief Commercial Officer Chris Freeman disposes of $ 10.75 million in common sharesGuardant Health Chief Commercial Officer Chris Freeman exercised stock options for 63,605 shares on A","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nNDL4khYKk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Guardant Health Chief Commercial Officer Chris Freeman Disposes of $ 10.75 Million in Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","GH","HELX","LU0320765992.SGD","FFOX","BK4585","LU0109394709.USD","LFSC","BK4535","BK4588","PTH","BK4551","GNOM","GDOC","EKG","LU0889565916.HKD","GNMX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658911089","title":"Axsome's Auvelity Strength Expected to Drive H2 Revenue Growth, RBC Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2658911089","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658911089?lang=en_us&edition=fundamental","pubTime":"2026-08-11 23:51","pubTimestamp":1786463486,"startTime":"0","endTime":"0","summary":"Axsome Therapeutics'  Q2 results showed continued strength from Auvelity, its treatment for major depressive disorder, with the drug's new indication expected to drive revenue growth in H2, RBC Capital Markets said Monday in a report.Auvelity generated $180 million in revenue in the quarter, topping Wall Street's $176 million estimate, \"which may help to drive some incremental upside as investors lift their outlook for the drug,\" the report said.Continued expansion of Auvelity's use in major depressive disorder, including potential benefits from long-term care, should support total revenue of $804 million in 2026, the report said.Auvelity sales may reach $4.3 billion by 2035, with peak sales potentially reaching $5 billion to $6 billion, and the longer-term opportunity is still not fully reflected in Axsome's share price, the report said.RBC lowered its price target on Axsome stock to $297 from $304 and maintained its outperform rating.Price: 220.55, Change: -0.34, Percent Change: -0.1","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","BK4585","BK4505","AXSM","PTH","LU2324357040.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658115349","title":"Tango Falls After Wider-than-Expected Quarterly Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2658115349","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658115349?lang=en_us&edition=fundamental","pubTime":"2026-08-11 23:18","pubTimestamp":1786461505,"startTime":"0","endTime":"0","summary":"BUZZ-Tango falls after wider-than-expected quarterly loss** Shares of drug developer Tango TherapeuticsTNGX.Ofall 3.3% to $26.75** Co reportsQ2 lossof 37 cents/share, vs. analysts' average loss estima","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nL4N44814E:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TNGX","LU1066051498.USD","LU1934455863.HKD","BK4583","LU1674673428.USD","BK4585","LU0965509010.AUD","LU0861579265.USD","BIB","LU0109394709.USD","LU0320765992.SGD","MEDI","BBH","PTH","LU1778281490.HKD","GILD","CANC","IE00BZ1G4Q59.USD","IE00B2B36J28.USD","LU2087621335.USD","LU2089984988.USD","IBBQ","LU2468319806.SGD","RVMD","BMED","IBB","IE0009355771.USD","IE0002270589.USD","LU2324357040.USD","SG9999015952.SGD","IE00B19Z3581.USD","LU0289739699.SGD","BK4532","LU1037948897.HKD","LU0114720955.EUR","IE00B7SZLL34.SGD","LU1934455277.USD","IE00BJJMRZ35.SGD","LU1674673691.USD","IE00BJT1NW94.SGD","IDNA","TBXU","LU0889565916.HKD","LU1066053197.SGD","IE00B4R5TH58.HKD","LU0234570918.USD","BK4588","TMED","BK4139","LU0965508806.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658064919","title":"Analysts Offer Insights on Healthcare Companies: Cardinal Health (CAH), Axsome Therapeutics (AXSM) and BridgeBio Pharma (BBIO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658064919","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658064919?lang=en_us&edition=fundamental","pubTime":"2026-08-11 23:00","pubTimestamp":1786460418,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Cardinal Health (CAH), Axsome Therapeutics (AXSM) an...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-cardinal-health-cah-axsome-therapeutics-axsm-and-bridgebio-pharma-bbio-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-cardinal-health-cah-axsome-therapeutics-axsm-and-bridgebio-pharma-bbio-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0052756011.USD","LU0310799852.SGD","LU1267930490.SGD","LU0889566641.SGD","LU1571399168.USD","BBIO","LU0211327993.USD","LU0029874061.USD","LU0154236417.USD","LU1983299246.USD","BK4137","HCSG","BK4581","BK4007","CAH","LABU","LU1267930227.SGD","LU0128526141.USD","LU0128525689.USD","BK4175","LU0072461881.USD","SG9999001440.SGD","BK4588","LU0211328371.USD","LU0162691827.USD","LU1267930813.SGD","LU1880398554.USD","LU0792757196.USD","XLV","LU1880398471.USD","PTH","BK4139","LU0006061336.USD","LU2324357040.USD","LU0310800965.SGD","XBI","BK4505","BK4585","AXSM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658919566","title":"Axsome Therapeutics Analysts Increase Their Forecasts Following Q2 Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2658919566","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658919566?lang=en_us&edition=fundamental","pubTime":"2026-08-11 22:30","pubTimestamp":1786458628,"startTime":"0","endTime":"0","summary":"Axsome Therapeutics (NASDAQ:AXSM) reported Q2 losses of 99 cents per share and sales of $218.4 million, missing analyst estimates. Analysts have mixed price targets for the stock.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/analyst-stock-ratings/price-target/26/08/61112506/axsome-therapeutics-analysts-increase-their-forecasts-following-q2-results","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PTH","BK4007","BK4505","LU2324357040.USD","BK4585","AXSM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658130309","title":"U.S. Stocks on the MOVE-Duke Energy, Sea, Cardinal Health","url":"https://stock-news.laohu8.com/highlight/detail?id=2658130309","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658130309?lang=en_us&edition=fundamental","pubTime":"2026-08-11 21:21","pubTimestamp":1786454464,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Duke Energy, Sea, Cardinal HealthAugust 11 (Reuters)-Wall Street's main indexes were poised to open higher on Tuesday as investors welcomed a report suggesting the United ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nL6N4480DV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","LU2089985449.USD","LU2362540622.SGD","LU1244550577.SGD","NET","SG9999006266.SGD","LU1621768206.USD","BK4547","ASTN","IE0034224299.USD","BK4077","LU0175139822.USD","LU0289739343.SGD","LU1861559042.SGD","LU1242518931.SGD","SE","ASTS","FPWR","LU1242518857.USD","LU1861220033.SGD","LU1048588211.SGD","LU1861217088.USD","IE00BJJMRZ35.SGD","ESPO","LU1244550221.USD","AIS","CRWG","LU0532188223.SGD","SG9999005177.SGD","IE00BFTCPJ56.SGD","LU1267930813.SGD","LU2125910849.SGD","TTWO","LU0719512351.SGD","BK4524","NETG","BK4212","LU0589944569.HKD","BK4505","IE0009354923.USD","LU0061475181.USD","LU1323610961.USD","NETX","VPU","LU0889565916.HKD","BK4146","LU1267930490.SGD","LU0210637038.USD","LU2045819591.USD","LU2065171311.SGD","BK4202","LU0499858602.USD","LU2065171402.SGD","LU2265009873.SGD","LU1621767810.EUR","BK4613","LU0792757196.USD","CANC","LU0128525689.USD","WARP","BK4564","BK4220","BK4116","XLC","GLAM","BK4560","IDNA","IDU","LU0154236417.USD","IE000M9KFDE8.USD","STTK","JXI","VG","XITK","ACIU","SIMO","LU0511384066.AUD","BK4535","DUK","BK4581","BYND","CAH","LU0052756011.USD","CWVX","LU1621768115.EUR","LU0310799852.SGD","BK4585","SG9999001135.SGD","LU1861558580.USD","WSPC","BNGE","LU0057025933.USD","LU2177674079.SGD","BK4081","CRWV","BK4606","SG9999004360.SGD","SG9999014492.USD","HIMZ","LU0289960550.SGD","PTH","LU2286300806.USD","BK4588","CORD","CWII","LU1839390173.USD","LU0348788117.USD","UPW","LU0345776255.USD","LU0441851309.USD","BK4085","URAN","LU0823039010.USD","XDAT","LU1861220207.SGD","HEAL","LU0006061336.USD","SG9999013486.USD","LU0823038988.USD","BK4213","LU0889566641.SGD","LU2384288077.EUR","LU0979878070.USD","LU1571399168.USD","LU1585245621.USD","LU0211327993.USD","LU2362541513.USD","BK4551","LU0345775950.USD","SG9999001440.SGD","HIMS","BK4526","BBH","LU2065170008.USD","LU0274383776.USD","RVMD","SG9999014484.SGD","LU0082616367.USD","LU0516422952.EUR","LU1244550494.USD","IE00B29SXK94.USD","LU0081259029.USD","SFD","NUKX","LEGN","LU1280957306.USD","LU1880398471.USD","LU2360107671.USD","BK4023","IE00B29SXL02.USD","LU0499858438.USD","MARS","BK4554","FXG","CLOU","BK4548","LU0072462343.USD","BK4089","BK4218","SG9999013478.USD","THNR","LU0069063385.USD","IE0002141913.USD","FSPC","LU0572939691.SGD","BK4503","FUTY","UFO","LU2362541273.HKD","HIYY","LU1267930227.SGD","LU0516422366.SGD","LU1880398554.USD","BK4007","LU0320765992.SGD","ONON","HERO","BK4607","WBTN","JAN","CRWU","LU0516423174.USD","LU2125910500.SGD","LU1430594728.SGD","LU2065169927.USD","LU2152927971.USD","BK4141","SG9999002950.SGD","IE0031814969.USD","LU0264606111.USD","RKLZ","LU0640476718.USD","XLU","DIPR","LU2290526834.HKD","LU1983299246.USD","BK4225","MEDI","LU0310800965.SGD","LU0472753341.HKD","LU2543165471.USD","SG9999002406.SGD","BK4615","BSP","IE0009355771.USD","LU0211328371.USD","LU2463526074.USD","BK4187","LU0572940350.SGD","FDNI","SGXZ58947870.SGD","TRUU","BK4566","HIMY","LU2008162690.USD","RHP","SG9999002414.USD","WTRE","LU0516422440.USD","BK4094","SG9999002620.SGD","SG9999002679.SGD","GAP","IE00BJT1NW94.SGD","LU1861215975.USD","MEMS","NERD","LU0289961442.SGD","RKLB","AHR","IE00B4R5TH58.HKD","LU0261945553.USD","RSPC","LU0251143029.SGD","NURE","UAA","LU2360107168.USD","BK4175","LU1804176565.USD","RKLX","LU2238330802.EUR","BK4181","LU0737861269.HKD","ORBX","SG9999002604.SGD","BK4120","IE00B2B36J28.USD","LTL","LU0072461881.USD","LU0516423091.SGD","LU1621767737.EUR","ASTX","LU0048573645.USD","LU1770036033.HKD","LU0109394709.USD","BK4139","IE0001KFT4U8.USD","SG9999013460.SGD","IE00BD6J9T35.USD","HMYY","LU0162691827.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658528997","title":"Truist Raises Revolution Medicines PT on Lung Cancer Pipeline Potential","url":"https://stock-news.laohu8.com/highlight/detail?id=2658528997","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658528997?lang=en_us&edition=fundamental","pubTime":"2026-08-11 19:41","pubTimestamp":1786448509,"startTime":"0","endTime":"0","summary":"BUZZ-Truist raises Revolution Medicines PT on lung cancer pipeline potential** Brokerage Truist Securities raises price target for Revolution MedicinesRVMD.Oto $231 from $210** Maintains \"buy\" rating** Says recent advancement of elironrasib and zoldonrasib into late-stage studies in first-line non-small cell lung cancer  strengthens RVMD's position in RAS-targeted cancers** Sees both programs expanding RVMD's addressable market in lung cancer and supporting a more diversified RAS franchise**The new price target represents a 11.6% upside to the stock's last close** Brokerage continues to expect potential approval ofdaraxonrasibin previously treated pancreatic cancer in Q3 2026** \"While pricing remains an open question, mgmt expressed confidence that organizational, market access, patient-support and distribution capabilities will not be limiting factors\" - Truist says** As of last close, stock has more than doubled YTD","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nL4N4480SP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CANC","IE00B4R5TH58.HKD","PTH","LU0889565916.HKD","RVMD","IE0002141913.USD","IE00BJT1NW94.SGD","IE0009355771.USD","LU0320765992.SGD","BBH","IE0009354923.USD","IE00B2B36J28.USD","IDNA","IE00BJJMRZ35.SGD","BK4139","LU0109394709.USD","IE00BFTCPJ56.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658925009","title":"Fennec Pharmaceuticals Q2 Sales Rise on Pedmark Demand","url":"https://stock-news.laohu8.com/highlight/detail?id=2658925009","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658925009?lang=en_us&edition=fundamental","pubTime":"2026-08-11 19:10","pubTimestamp":1786446639,"startTime":"0","endTime":"0","summary":"Fennec Pharmaceuticals Q2 sales rise on PEDMARK demandOverviewUS specialty pharma's Q2 net product sales rose 78% yr/yr, driven by PEDMARK demandNon-GAAP adjusted EBITDA for Q2 turned positive from a ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nL1N4480DE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HRTX","BK4505","BK4139","FENC","BK4007","LU2324357040.USD","BK4585","AXSM","PTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1123475942","title":"BEONE MEDICINES Surges Over 4% in Morning Trading on Strategic Partnership with Revolution Medicines to Accelerate RAS Drug Development","url":"https://stock-news.laohu8.com/highlight/detail?id=1123475942","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1123475942?lang=en_us&edition=fundamental","pubTime":"2026-08-11 09:46","pubTimestamp":1786412777,"startTime":"0","endTime":"0","summary":"BEONE MEDICINES (06160) saw its shares surge more than 4% during early trading hours, before settling at a 2.72% gain to 219 Hong Kong dollars, with a trading volume of 297 million Hong Kong...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KURE","RVMD","IE0009355771.USD","LU2328871848.SGD","IE00BFTCPJ56.SGD","LU1719994722.HKD","06160","CANC","LU0109394709.USD","LU0889565916.HKD","IE00BJJMRZ35.SGD","LU1251922891.USD","LU0828237510.HKD","LU0307460666.USD","688235","BK4139","BK4585","LU1770034418.SGD","IE00B2B36J28.USD","BK1161","IE00B4R5TH58.HKD","BK4526","ONC","BK1583","BK1588","LU0320765992.SGD","IDNA","IE0009354923.USD","VXUS","PTH","KCAI","BK4588","LU0588546209.SGD","BK1500","LU1969619763.USD","LU1303224171.USD","BK0239","LU0228659784.USD","IE00BJT1NW94.SGD","IE0002141913.USD","BBH"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":8,"totalSize":200,"code":"91000000","status":"200"}]}}